Tagged with Rare Diseases

Why We Need to Work Year-Round to Reduce the Burden of Rare Respiratory Diseases
Cornelia Zanetti – General Manager, Takeda Greece, Cyprus & Malta
Maria Gabriela Pittis – Head of South Cone, Andean Region, Mexico & Central America and Caribbean, Takeda
Giannis Sotiriou – CEO, Institute of Pharmaceutical Research and Technology (IFET), Greece
Germany Pharma News: Bayer CEO on Thin Ice; Merck Manufacturing Expansion; STADA Launches First Rare Kidney Disease Drug
Dirk Van Niekerk – Managing Director South America, Boehringer Ingelheim
Eriona Gjinukaj, Chief Operating Officer – Dompé
Rare Diseases: Reverse Engineering for Drug Development
Norberto Villarrasa Justicia – Cluster Head Spain, Italy & Portugal, Kyowa Kirin
Orphan Drugs: EURORDIS & EFPIA Push for Broader Access
Orphan Drugs & Rare Diseases: Brazil
Pierluigi Antonelli – CEO, Angelini Pharma
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here